Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$26.12 - $34.07 $26.8 Million - $35 Million
-1,027,402 Reduced 38.54%
1,638,108 $55.8 Million
Q1 2024

May 15, 2024

BUY
$26.64 - $40.31 $2.7 Million - $4.09 Million
101,452 Added 3.96%
2,665,510 $93.8 Million
Q4 2023

Feb 14, 2024

BUY
$19.95 - $31.0 $15.3 Million - $23.8 Million
767,225 Added 42.7%
2,564,058 $74 Million
Q3 2023

Nov 14, 2023

BUY
$21.33 - $59.42 $1.28 Million - $3.57 Million
60,058 Added 3.46%
1,796,833 $41.2 Million
Q2 2023

Aug 14, 2023

BUY
$34.33 - $62.11 $22.7 Million - $41.1 Million
662,490 Added 61.67%
1,736,775 $99.6 Million
Q1 2023

May 15, 2023

SELL
$26.01 - $48.69 $12.1 Million - $22.6 Million
-463,504 Reduced 30.14%
1,074,285 $40.4 Million
Q4 2022

Feb 14, 2023

BUY
$24.14 - $30.37 $698,177 - $878,361
28,922 Added 1.92%
1,537,789 $41.1 Million
Q3 2022

Nov 15, 2022

SELL
$22.23 - $33.37 $10.4 Million - $15.6 Million
-466,939 Reduced 23.63%
1,508,867 $42.7 Million
Q2 2022

Aug 15, 2022

BUY
$19.74 - $43.01 $15.3 Million - $33.3 Million
774,789 Added 64.51%
1,975,806 $42.9 Million
Q1 2022

May 16, 2022

BUY
$36.25 - $52.02 $8.25 Million - $11.8 Million
227,635 Added 23.39%
1,201,017 $48.2 Million
Q4 2021

Feb 14, 2022

BUY
$43.27 - $65.72 $2.79 Million - $4.24 Million
64,447 Added 7.09%
973,382 $46.1 Million
Q3 2021

Nov 15, 2021

BUY
$53.61 - $67.5 $2.52 Million - $3.18 Million
47,082 Added 5.46%
908,935 $51.5 Million
Q2 2021

Aug 16, 2021

BUY
$45.13 - $64.99 $28 Million - $40.3 Million
620,326 Added 256.84%
861,853 $49.5 Million
Q1 2021

May 17, 2021

SELL
$29.77 - $84.85 $56,711 - $161,639
-1,905 Reduced 0.78%
241,527 $15.3 Million
Q4 2020

Feb 16, 2021

BUY
$25.66 - $34.55 $401,373 - $540,431
15,642 Added 6.87%
243,432 $8.17 Million
Q3 2020

Nov 10, 2020

BUY
$22.51 - $30.11 $135,712 - $181,533
6,029 Added 2.72%
227,790 $6.23 Million
Q2 2020

Aug 14, 2020

BUY
$12.65 - $29.57 $665,427 - $1.56 Million
52,603 Added 31.1%
221,761 $6 Million
Q1 2020

May 11, 2020

BUY
$10.84 - $20.85 $1.83 Million - $3.53 Million
169,158 New
169,158 $2.48 Million

Others Institutions Holding MORF

About Morphic Holding, Inc.


  • Ticker MORF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,477,100
  • Market Cap $2.19B
  • Description
  • Morphic Holding, Inc., a biopharmaceutical company, discovers and develops oral small-molecule integrin therapeutics for the treatment of autoimmune, cardiovascular, metabolic diseases, as well as fibrosis and cancer. Its lead product candidates are MORF-057, an a4ß7-specific integrin inhibitor affecting inflammation that is in Phase 1 clinical ...
More about MORF
Track This Portfolio

Track State Street Corp Portfolio

Follow State Street Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.